Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04941807 · ClinicalTrials.gov registry record · Phase 4
Use of Platelet-rich Plasma (PRP) Therapy in Patients With Brittle Nail Syndrome
A Phase 4 study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 4
- Development phase
- 11
- Enrollment target
NCT04941807 is a Phase 4 study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 11 participants.
The verdict
NCT04941807, a Phase 4 study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the efficacy and safety of platelet-rich plasma therapy for brittle nail syndrome
Interventions
- DEVICE Platelet-rich plasma
- DEVICE Platelet-poor plasma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2021-03-04 |
| Est. Completion | 2023-04-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04941807
The ClinicalTrials.gov registry entry for NCT04941807 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Platelet-rich plasma is the first listed.
NCT04941807 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04941807 about?
NCT04941807 is a clinical study titled "Use of Platelet-rich Plasma (PRP) Therapy in Patients With Brittle Nail Syndrome". The purpose of this study is to assess the efficacy and safety of platelet-rich plasma therapy for brittle nail syndrome
What is the current status of trial NCT04941807?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 11 participants. The study started on 2021-03-04. Estimated completion is 2023-04-12.
What interventions are being tested in trial NCT04941807?
The interventions under investigation include: Platelet-rich plasma (DEVICE), Platelet-poor plasma (DEVICE).
Who is sponsoring clinical trial NCT04941807?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.